Only now the Natural Birth package is 2 000 PLN cheaper at Medicover Hospital!

Professional care during childbirth and comfortable stay conditions.

1500 visits available 1500 visits available
 3788 doctors 3788 doctors
1800 blood tests and services 1800 blood tests and services
Verified opinions Verified opinions
Mediclub

Thrombophilia - Basic Panel (MTHFR + F2 + F5)

Identification of mutations predisposing to thrombosis in the patient's genetic material. The test includes identification of mutations in the Factor V (F5) gene, mutations in the Prothrombin (F2) gene, and polymorphisms in the MTHFR gene.

Product to be shipped

Product to be shipped

To be done at home

To be done at home

Step-by-step instruction

Step-by-step instruction

Easy to use

Easy to use

PLN 349.00 PLN 331.55
Lowest price from 30 days before discounting PLN 331.55

Available in stock

Fast turnaround time

Secure courier delivery

Convenience and comfort of shopping

Fast shipping

Directly from the manufacturer

Secure payments

Blik, Przelewy24

Thrombophilia - Basic Panel (Gene Mutations: F5, F2, MTHFR)

Thrombophilia is defined as a predisposition to thrombosis. Thrombosis is a pathological process where a blood clot forms within the blood vessel. When a clot forms in an artery, it is called arterial thrombosis; when it forms in a vein, it is called venous thrombosis. The most common site for venous thrombosis is the veins of the lower limbs and pelvis. Clots in the coronary artery can lead to heart attacks. Thrombosis may be hereditary or acquired.

Causes of Acquired Thrombophilia:

  • Antiphospholipid syndrome
  • Systemic lupus erythematosus
  • Rheumatoid arthritis
  • Dermatomyositis
  • Infections and inflammatory conditions: ulcerative colitis, Crohn's disease
  • Cancers and chemotherapy: leukemias, lymphomas, colorectal cancer, lung cancer

Causes of Hereditary Thrombophilia:

  • Mutations in the Factor V gene (F5)
  • Mutations in the Prothrombin gene (F2)
  • Deficiencies in coagulation inhibitors due to gene mutations: antithrombin (SERPINC1 gene mutation), protein C (PROC gene mutation), and protein S (PROS1 gene mutation). Antithrombin (AT), protein C (PC), and protein S (PS) are endogenous inhibitors of the coagulation process.
  • Polymorphisms in the Methylenetetrahydrofolate reductase gene (MTHFR)
  • Polymorphisms in the Plasminogen Activator Inhibitor-1 gene (PAI1)

Most Common Symptoms of Thrombosis:

  • Asymmetrically swollen limbs
  • Cyanosis of the feet and lower legs
  • Pain upon walking
  • Pain and redness at the site of swelling
  • Dilated blood vessels
  • Accelerated heart rate
  • Chest pain

Purpose of the Test:

Identification of mutations predisposing to thrombosis in the patient's genetic material. The test includes identifying mutations in the Factor V (F5) gene, mutations in the Prothrombin (F2) gene, and polymorphisms in the MTHFR gene.

These Mutations:

  • Are the most common causes of hereditary thrombophilia
  • Increase the risk of venous and arterial thrombosis, heart attacks, and strokes
  • Contribute to cardiovascular diseases, including thromboembolic complications

In Pregnant Women:

  • Increase the risk of recurrent miscarriages
  • May lead to premature separation of the placenta
  • May cause the development of preeclampsia
  • May cause fetal growth restriction
  • May result in intrauterine fetal death
  • May lead to neural tube defects and cleft lip and palate in the fetus

Indications for Testing:

  • Symptoms of thromboembolic disease
  • Family history of thrombophilia
  • Previous thrombotic events
  • Planned surgery requiring long-term immobilization
  • Recurrent miscarriages or stillbirths
  • Use of hormonal contraception
  • Use of hormone replacement therapy
  • Thrombocytopenia
  • Cancer
  • Sedentary lifestyle
  • Obesity
     

Method:

Real-time PCR

High test sensitivity – 99%
 

Sample Required:

EDTA blood

Oral swab

Recently viewed: